SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-016878
Filing Date
2021-12-16
Accepted
2021-12-16 16:01:20
Documents
14
Period of Report
2021-12-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ampe-20211216x8k.htm   iXBRL 8-K 35232
2 EX-99.1 ampe-20211216xex99d1.htm EX-99.1 20097
3 GRAPHIC ampe-20211216xex99d1001.jpg GRAPHIC 3430
  Complete submission text file 0001558370-21-016878.txt   185657

Data Files

Seq Description Document Type Size
4 EX-101.SCH ampe-20211216.xsd EX-101.SCH 3220
5 EX-101.LAB ampe-20211216_lab.xml EX-101.LAB 15501
6 EX-101.PRE ampe-20211216_pre.xml EX-101.PRE 10516
7 EXTRACTED XBRL INSTANCE DOCUMENT ampe-20211216x8k_htm.xml XML 4728
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35182 | Film No.: 211497778
SIC: 2834 Pharmaceutical Preparations